News

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...
A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, ...
Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...
“Lung cancer is a disease where uncontrolled cell growth occurs in the lung leading to tumours,” explains Dr Jenny Messenger, ...
England's NHS pioneers a revolutionary blood test for faster cancer diagnosis and treatment. This 'liquid biopsy' detects ...
Researchers have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS ...
CHICAGO -- Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response ...
If you don't feel hungry as much as you used to, or you are not wanting to eat as much food as you would usually, this could ...
Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...
A new blood test will be offered to lung cancer patients in a move that NHS England says will benefit about 15,000 people ...
Genetic testing for hereditary cancer unexpectedly uncovered a case of myelodysplastic syndrome (MDS), highlighting the need ...
The FDA has granted clearance to the IND applications for both the therapeutic ( [ 225 Ac]Ac-AKY-1189) and imaging ( [ 64 ...